The effects of intradermal bradykinin are potentiated by angiotensin converting enzyme inhibitors in hypertensive patients.
Open accessThe DOI matches its Crossref record.
Abstract
1. To test the hypothesis that angiotensin converting enzyme (ACE) inhibitors potentiate the tissue effects of bradykinin, the thickness of weals produced by intradermal injections of bradykinin was measured in 17 hypertensive subjects whose antihypertensive regimen included an ACE inhibitor, and in 12 whose treatment did not. 2. Weal thickness increased linearly with the logarithm of the bradykinin dose in both groups (P less than 0.0001). 3. The patients receiving ACE inhibitors showed a mean response of 1.18 +/‐ 0.08 mm (mean +/‐ s.e. mean), compared with a mean response of 0.75 +/‐ 0.08 mm for patients not receiving an ACE inhibitor (P = 0.002). Mean weal response (1.08 +/‐ 0.9 mm) was not significantly different in patients taking captopril (n = 11) compared with that (1.29 +/‐ 0.12 mm) in patients taking enalapril (n = 9). 4. Facial flushing during the experiment occurred in six patients taking ACE inhibitors but none who were not. 5. Dermal responses to bradykinin are enhanced in patients taking ACE inhibitors as routine antihypertensive therapy. This study supports the hypothesis that bradykinin may be responsible for some of the adverse effects of these drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Israili, Z. H., & Hall, W. D. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-3-234 · Cited by 910
ACE Inhibitor???Induced Angioedema: Incidence, Prevention and Management
Vleeming, W., van Amsterdam, J. G. C., Stricker, B. H., & de Wildt, D. J. (1998) · Drug Safety · doi:10.2165/00002018-199818030-00003 · Cited by 243
Increased sensitivity to bradykinin among African Americans
Gainer, J. V., Nadeau, J. H., Ryder, D., & Brown, N. J. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)70151-3 · Cited by 89
Kim, K.-S., Kumar, S., Simmons, W. H., & Brown, N. J. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35290-5 · Cited by 45
Metadata
- Authors
- Ferner, R., Wilson, D., Paterson, J. R., Wilkinson, R., & Rawlins, M.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 1989-03
- Volume
- 27
- Issue
- 3
- Pages
- 337-342
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W2042366793
- Cited by
- 21
- References
- 0
- FWCI
- 2.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The effects of intradermal bradykinin are potentiated by angiotensin converting enzyme inhibitors in hypertensive patients. https://app.cochat.ai/papers/10.1111/j.1365-2125.1989.tb05374.x
- The paper
- Ferner, R., Wilson, D., Paterson, J. R., Wilkinson, R., & Rawlins, M. (1989). The effects of intradermal bradykinin are potentiated by angiotensin converting enzyme inhibitors in hypertensive patients. British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-2125.1989.tb05374.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.